Literature DB >> 34369109

Long-term extension study of tofacitinib in refractory dermatomyositis.

Julie J Paik1, Matthew Shneyderman1, Laura Gutierrez-Alamillo1, Jemima Albayda1, Eleni Tiniakou1, Jamie Perin1, Grazyna Purwin1, Sherry Leung1, Doris Leung1, Livia Casciola-Rosen1, Andrew S Koenig2, Lisa Christopher-Stine1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34369109      PMCID: PMC8863430          DOI: 10.1002/art.41944

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN: 2326-5191            Impact factor:   10.995


× No keyword cloud information.
  1 in total

1.  Study of Tofacitinib in Refractory Dermatomyositis: An Open-Label Pilot Study of Ten Patients.

Authors:  Julie J Paik; Livia Casciola-Rosen; Joseph Yusup Shin; Jemima Albayda; Eleni Tiniakou; Doris G Leung; Laura Gutierrez-Alamillo; Jamie Perin; Liliana Florea; Corina Antonescu; Sherry G Leung; Grazyna Purwin; Andrew Koenig; Lisa Christopher-Stine
Journal:  Arthritis Rheumatol       Date:  2021-03-24       Impact factor: 10.995

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.